---
$id: https://graph.org.ai/products/commodity/51111602
$type: Product
source: UNSPSC
code: "51111602"
title: "Cytarabine"
class: "51111600"
classTitle: "Antimetabolites"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Cytarabine

**UNSPSC Code**: 51111602
**Class**: [Antimetabolites](Antimetabolites.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antimetabolite, antineoplastic, antiviral agent, and immunosuppressive agent with the molecular formula C9H13N3O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 04079A1RDZ, chemically known as 4-amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidine but generally known as cytarabine, which bears US NIH Compound Identifier 596. European Medicines Agency schedules Cytarabine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06880MIG. The term CYTARABINE is an International Non-Proprietary Name. World Health Organization schedules cytarabine in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule cytarabine under HS 29349990 and SITC 51579. As of Q4 2014, CYTARABINE remains the US FDA Preferred Term for this commodity. Cytarabine bears US NLM identifiers UMLS ID C0010711 and NCI Concept Code C408. SMILES: O1C(N2CCC(NC2=O)N)C(O)C(O)C1CO.

